PolyTherics granted Nuron an exclusive license to its TheraPEG site-specific PEGylation technology to develop a long-acting NU100 interferon beta-1b to treat relapsing-remitting multiple sclerosis (RRMS)

PolyTherics Ltd.

U.K. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Nuron Biotech Inc.

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced